AWIQLI

Aperçu du produit

About AWIQLI

AWIQLI is a prescription medication containing the active ingredient INSULIN ICODEC, a long-acting insulin analog used in the management of diabetes mellitus type 1 and type 2. It helps regulate blood sugar levels by mimicking the action of the body's natural insulin.

Key Benefits & Uses

• Regulation of blood glucose levels in patients with diabetes mellitus type 1 and type 2.
• Improved glycemic control and reduced risk of diabetic complications.
• Convenient once-daily dosing for long-acting insulin control.

Active Ingredient & Action

INSULIN ICODEC, the active ingredient in AWIQLI, is a recombinant human insulin analog with a prolonged duration of action. It is designed to provide a steady and consistent release of insulin over a 24-hour period, helping to maintain stable blood glucose levels and reduce the risk of hypoglycemia.

Important Notes

AWIQLI should only be used under the guidance of a qualified healthcare professional. It is essential to follow the prescribed dosing regimen and monitor blood glucose levels regularly to ensure optimal glycemic control. Patients should be aware of the potential risks of hypoglycemia and take necessary precautions to avoid it.